<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32951348</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>10</Issue><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Promoting identification of amyotrophic lateral sclerosis based on label-free plasma spectroscopy.</ArticleTitle><Pagination><StartPage>2010</StartPage><EndPage>2018</EndPage><MedlinePgn>2010-2018</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51194</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Amyotrophic lateral sclerosis (ALS) is an adult-onset fatal neurodegenerative disease which lacks identified biological markers. A label-free plasma surface-enhanced Raman spectroscopy (SERS) method was developed to explore a simple and noninvasive test for ALS.</AbstractText><AbstractText Label="METHODS">ALS patients were enrolled serially and plasma samples were collected at the time of diagnosis prior to the start of ALS treatment. SERS spectra were recorded using a Renishaw micro-Raman system.</AbstractText><AbstractText Label="RESULTS">To exclude the interference by varying disease severity, we enrolled three groups of ALS patients, including ALS-1 (n&#xa0;=&#xa0;60; ALSFRS-R&#xa0;&#x2265;&#xa0;42 and time interval&#xa0;&#x2264;&#xa0;12&#xa0;months), ALS-2 (n&#xa0;=&#xa0;61; ALSFRS-R&#xa0;&lt;&#xa0;42 and time interval&#xa0;&#x2264;&#xa0;12&#xa0;months), and ALS-3 (n&#xa0;=&#xa0;61; ALSFRS-R&#xa0;&#x2265;&#xa0;38 and time interval&gt;&#xa0;12&#xa0;months). The SERS spectra were analyzed using principal component analysis (PCA), which showed that ALS-1, ALS-2, ALS-3, and control groups were separated significantly. Then, decision tree (DT) models and receiver operating characteristic curves were employed and identified that bands at 722 and 739&#xa0;cm<sup>-1</sup> , and ratios of 635-722&#xa0;cm<sup>-1</sup> and 635-739&#xa0;cm<sup>-1</sup> were able to distinguish ALS from controls significantly. Finally, we highlighted six metabolism pathways correlated with ALS, including phenylalanine-tyrosine-tryptophan biosynthesis, aminoacyl-tRNA biosynthesis, phenylalanine metabolism, pantothenate and CoA biosynthesis, porphyrin and chlorophyll metabolism, and pyrimidine metabolism.</AbstractText><AbstractText Label="INTERPRETATION">Plasma SERS could be a promising tool for the detection of ALS. The bands at 722 and 739&#xa0;cm<sup>-1</sup> , and the ratios of 635-722&#xa0;cm<sup>-1</sup> and 635-739&#xa0;cm<sup>-1</sup> could serve as potential indicator for ALS.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qi-Jie</ForeName><Initials>QJ</Initials><Identifier Source="ORCID">0000-0002-1311-5582</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Xiao-Huan</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Min-Lu</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Qi-Fu</ForeName><Initials>QF</Initials><AffiliationInfo><Affiliation>Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xue-Liang</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Key Laboratory of Optoelectronic Science and Technology for Medicine, Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Shang-Yuan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Key Laboratory of Optoelectronic Science and Technology for Medicine, Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C564688">Amyotrophic Lateral Sclerosis 3</SupplMeshName><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>20</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32951348</ArticleId><ArticleId IdType="pmc">PMC7545607</ArticleId><ArticleId IdType="doi">10.1002/acn3.51194</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet 2017;390:2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Liu T, Liu L, et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta&#x2010;analysis. J Neurol 2020;267:944&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pubmed">31797084</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ZJ, Lin HX, Wei Q, et al. Genetic spectrum and variability in Chinese patients with amyotrophic lateral sclerosis. Aging Dis 2019;10:1199&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6844596</ArticleId><ArticleId IdType="pubmed">31788332</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al&#x2010;Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med 2017;377:162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kneipp J, Kneipp H, Kneipp K. SERS&#x2013;a single&#x2010;molecule and nanoscale tool for bioanalytics. Chem Soc Rev 2008;37:1052&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pubmed">18443689</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong K, Kendall C, Stone N, Notingher I. Raman spectroscopy for medical diagnostics&#x2010;From in&#x2010;vitro biofluid assays to in&#x2010;vivo cancer detection. Adv Drug Deliv Rev 2015;89:121&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">25809988</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang QJ, Chen Y, Zou XH, et al. Prognostic analysis of amyotrophic lateral sclerosis based on clinical features and plasma surface&#x2010;enhanced Raman spectroscopy. J Biophotonics. 2019;12:e201900012 10.1002/jbio.201900012</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.201900012</ArticleId><ArticleId IdType="pubmed">30989810</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlomagno C, Banfi PI, Gualerzi A, et al. Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis. Sci Rep 2020;10:10175 10.1038/s41598-020-67138-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67138-8</ArticleId><ArticleId IdType="pmc">PMC7311476</ArticleId><ArticleId IdType="pubmed">32576912</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Leopold N, Lendl B. A new method for fast preparation of highly surface&#x2010;enhanced Raman scattering (SERS) active silver colloids at room temperature by reduction of silver nitrate with hydroxylamine hydrochloride. J Phys Chem B 2003;107:5723&#x2013;5727.</Citation></Reference><Reference><Citation>Zhao J, Lui H, McLean DI, Zeng H. Automated autofluorescence background subtraction algorithm for biomedical Raman spectroscopy. Appl Spectrosc 2007;61:1225&#x2013;1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">18028702</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacio A, Dalla Marta S, Spizzo R, et al. Surface&#x2010;enhanced Raman spectroscopy of blood plasma and serum using Ag and Au nanoparticles: a systematic study. Anal Bioanal Chem 2014;406:2355&#x2013;2365.</Citation><ArticleIdList><ArticleId IdType="pubmed">24493335</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S, Wang W, Tai IT, et al. Label&#x2010;free surface&#x2010;enhanced Raman spectroscopy for detection of colorectal cancer and precursor lesions using blood plasma. Biomed Opt Express 2015;6:3494&#x2013;3502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4574674</ArticleId><ArticleId IdType="pubmed">26417518</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsagova Kralova Z, Orinak A, Orinakova R, et al. Electrochemically deposited silver detection substrate for surface&#x2010;enhanced Raman spectroscopy cancer diagnostics. J Biomed Opt 2018;23:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">29981226</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009;65(Suppl 1):S3&#x2013;S9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19191304</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Hardiman O, Benatar M, et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 2013;12:310&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Kim JR, van Bruggen R, Park J. RNA&#x2010;binding proteins in amyotrophic lateral sclerosis. Mol Cells 2018;4:818&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis DI, Goodacre R. Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. Analyst 2006;131:875&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pubmed">17028718</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ. DNA damage and repair: relevance to mechanisms of neurodegeneration. J Neuropathol Exp Neurol 2008;67:377&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2474726</ArticleId><ArticleId IdType="pubmed">18431258</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BW, Jeong YE, Wong M, Martin LJ. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC&#x2010;derived motor neurons with SOD1 mutations. Acta Neuropathol Commun 2020;8:7 10.1186/s40478-019-0874-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0874-4</ArticleId><ArticleId IdType="pmc">PMC6995159</ArticleId><ArticleId IdType="pubmed">32005289</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran&#x2010;Heravi Y, Van Broeckhoven C, van der Zee J. Stress granule mediated protein aggregation and underlying gene defects in the FTD&#x2010;ALS spectrum. Neurobiol Dis 2019;134:104639 10.1016/j.nbd.2019.104639</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104639</ArticleId><ArticleId IdType="pubmed">31626953</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#x142;zecka J, Stelmasiak Z, Solski J, et al. Plasma amino acids percentages in amyotrophic lateral sclerosis patients. Neurol Sci 2003;24:293&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">14658054</ArticleId></ArticleIdList></Reference><Reference><Citation>Patin F, Corcia P, Vourc'h P, et al. Omics to explore amyotrophic lateral sclerosis evolution: the central role of arginine and proline metabolism. Mol Neurobiol 2017;54:5361&#x2013;5374.</Citation><ArticleIdList><ArticleId IdType="pubmed">27590138</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>